pre-seed
Stage
1
Investors
About
KYLYS is a life science spin-off from the University of Geneva that develops innovative hyaluronic acid-based biocompatible and biodegradable gels for medical treatments and aesthetic solutions, designed to provide long-lasting effects and enhanced safety upon injection.
Explore KYLYS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.